Skip to main content

A new proposal for citation data

Researchers have proposed a new scheme for ranking the quality or impact of scientific journals that they say is more accurate than the Impact Factor, according to a linkurl:paper;https://www.plosone.org/article/fetchArticle.action?articleURI=info:doi/10.1371/journal published last week in PLoS ONE. Rather than relying on an average of citations to rate a journal, the system uses a mathematical model to characterize the typical number of citations that papers in specific journals are likely to r

Written byAlla Katsnelson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Researchers have proposed a new scheme for ranking the quality or impact of scientific journals that they say is more accurate than the Impact Factor, according to a linkurl:paper;https://www.plosone.org/article/fetchArticle.action?articleURI=info:doi/10.1371/journal published last week in PLoS ONE. Rather than relying on an average of citations to rate a journal, the system uses a mathematical model to characterize the typical number of citations that papers in specific journals are likely to receive. Since its inception in the 1960's by the Institute for Scientific Information (now Thomson Scientific), the Impact Factor has become the standard journal ranking system. It's calculated by adding up all the citations published in a particular journal during a two year period and dividing that number by the total number of citable papers during that time. But linkurl:Luis Amaral;https://amaral.chem-eng.northwestern.edu/ at Northwestern University and colleagues say that method has two major problems. First, it relies on the mean value, which "seems like a very natural number," Amaral explained, but only if the distribution of what one is measuring is normal, i.e. bell-shaped -- not the case for paper citations. Amaral and his team looked though a database of 23 million papers published in more than 2,000 journals since 1955. The most cited paper in the pool got 200,000 citations, while half of all papers didn't get cited at all. "You have this really broad range, so the mean is a really bad measure to use," he said; if one paper in a given year receives 1000 citations, "no matter if none of the other papers have got many citations, that paper is going to change significantly the mean." The second problem with impact factor, he said, is that papers in different fields get cited at different rates. In medicine and physics, papers tend to get cited very quickly after they're published, while those in economics or math can take a couple of years to accumulate citations. That's true for individual journals within a field as well, he added. So they converted the number of citations of each paper to its logarithm, in order to "bring these numbers that are very broad closer to a narrower range." The logarithms of citations for individual papers did form a normal, bell-shaped distribution for within specific journals. Over time, the likelihood that a paper will get cited decreases, so its citations reach a stationary state, so the researchers then developed a mathematical model to predict how quickly papers in different journals acquired their "characteristic" number of citations. "That means there's a sort of pattern to a given journal," Amaral said, and that pattern is stable from year to year. Under their system, journal rankings change somewhat: Trends in Biochemical Science, for example, ranks quite highly according to the Impact Factor (13.863), above journals such as EMBO, Plant Cell, and the Journal of Biological Chemistry, but much lower, and below those others, in the new ranking system. (See data comparing the group's ranking system to the Impact Factor for journals in biochemistry and molecular biology linkurl:here;https://www.the-scientist.com/supplementary/pdf/MOLECULAR_BIOLOGY.pdf and cell biology journals linkurl:here.;https://www.the-scientist.com/supplementary/pdf/CELL_BIOLOGY.pdf ) In a good ranking system, papers from higher ranked journals should have higher numbers of citations than papers from lower ranked journals most of the time -- a criterion that, according to their analysis, their system (called q) meets better than the Impact Factor, Amaral said. Jim Pringle, vice president of product development at Thomson Scientific, wrote in an Emailed statement in response to the paper: "Thomson Scientific encourages experimentation and development of new citation-based methodologies and metrics. This particular article applies complex new mathematical techniques in a potentially interesting way. We look forward to the methodological discussion that will no doubt ensue." Pringle also directed readers to journals such as Scientometrics and the Journal of the American Society for Information Science and Technology (JASIST), and Thomson's recently launched linkurl:Citation Impact Forum,;https://scientific.thomson.com/citationimpactforum/ for further insight into rankings. What do you think about this method -- is it better or worse than the Impact Factor? Tell us in a comment; we promise not to take it personally. (The Impact Factor was developed by Eugene Garfield, who also founded The Scientist.)
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays